Buscar
Mostrando ítems 51-60 de 321
Intervención fisioterapéutica en fracturas de columna vertebral sin lesión medular
(Fundación Universitaria María CanoFacultad de Ciencias de la SaludMedellín, 2022)
Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: A network meta-analysis
(Oxford University Press, 2019)
Background: Osteoporosis and osteopenia are associated with increased fracture incidence in postmenopausal women. We aimed to determine the comparative effectiveness of various available pharmacological therapies. Methods: ...
Ten years' experience with alendronate for osteoporosis in postmenopausal women
(MASSACHUSETTS MEDICAL SOC, 2004)
Background: Antiresorptive agents are widely used to treat osteoporosis. We report the results of a multinational randomized, double-blind study, in which postmenopausal women with osteoporosis were treated with alendronate ...
Postmenopausal women with sarcopenia have higher prevalence of falls and vertebral fracturesLas mujeres postmenopáusicas con sarcopenia tienen mayor prevalencia de caídas y fracturas vertebrales
(Fundación Revista Medicina, 2021-02)
Recently, a new consensus of the European Working Group on Sarcopenia in Older People (EWSOP2) recommended new cut-off points for the diagnosis of sarcopenia. The aim of the present manuscript was to assess the prevalence ...
Alendronic acid produces greater effects than risedronic acid on bone density and turnover in postmenopausal women with osteoporosis - Results of FACTS-international
(Adis International LtdAucklandIrã, 2006)
A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24-month results from FACTS-International
(Blackwell PublishingOxfordInglaterra, 2008)